Healthcare
Thursday, August 11, 2016
BRIEF-Biosintez H1 net result to RAS turns to loss of RUB 64.8 million
* H1 net loss to Russian Accounting Standards (RAS) of 64.8
million roubles ($997,767.34) versus profit 6.5 million roubles
year ago
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment